Xeloda^®

Xeloda^® is the first FDA-approved oral (taken by mouth) chemotherapy for the treatment of metastatic breast cancer and metastatic colorectal cancer. It is also FDA approved for treatment of Dukes' C (stage III) colon cancer.

An advantage of Xeloda^® over other, similar forms of chemotherapy is that it can taken by mouth, instead of through sometimes painful or time-consuming transfusion procedures.

At Cancer Treatment Centers of America (CTCA), your cancer doctors and practitioners will work closely with each other—and you—to outline a personalized cancer treatment plan. Together, you'll decide whether Xeloda^® is appropriate for your needs. Your treatment plan will consist of an ideal combination of innovative, traditional and complementary/supportive therapies.

Chat now with an Oncology Information Specialist to learn more about our customized approach to cancer treatment at CTCA.

Some patients undergoing Xeloda^® treatment may experience the following serious side effects:

• Allergic reaction (difficulty breathing; closing of the throat; shortness of breath; swelling of the face, lips, or tongue; hives)
• Vomiting (multiple times during a 24-hour period)
• Diarrhea
• Loss of appetite
• Nausea
• Fever (or other signs of infection)
• Hand-and-foot syndrome (pain, swelling, tingling, or numbness in your hands and/or feet)
• Pain, sores, redness, or swelling in or around the mouth

Other less serious side effects are also frequently reported during Xeloda^® treatment:

• Rash (or dry/itchy skin)
• Eye irritation
• Dehydration
• Fatigue
• Sleeplessness
• Dizziness
• Headaches
• Constipation

Because each patient is unique, you may experience additional side effects not mentioned in the lists above. It is important to communicate any side effects you encounter as a result of cancer treatment with Xeloda^® to your healthcare professional.

At Cancer Treatment Centers of America (CTCA), your team of cancer experts will keep you well informed of the potential side effects of Xeloda^®, in addition to other treatment options for your metastatic breast cancer or colorectal cancer. As part of your customized treatment plan, we offer a range of supportive therapies to treat both your mind and spirit during this difficult time.

Xeloda^® is used in combination with Taxotere^® to treat breast cancer which has spread to other parts of the body (metastatic breast cancer). Xeloda^® is also used in instances in which metastatic breast cancer patients have not improved following treatment with other medicines (such as paclitaxel and anthracycline-containing medicines, including doxorubicin).

For patients with stage III colon cancer, Xeloda^® is an approved form of adjuvant (following surgery) therapy. Xeloda^® is also approved for treatment of metastatic colorectal cancer.

At our cancer hospitals, your team of specialists will work together to gain a full understanding of where the cancer exists in your body, and will determine if Xeloda^® is the right treatment for you.

Discover our unique approach to breast and colon cancer treatment today. Please click to chat with an Oncology Information Specialist.